Prospective Study
Copyright ©The Author(s) 2019.
World J Clin Cases. Dec 6, 2019; 7(23): 3990-4003
Published online Dec 6, 2019. doi: 10.12998/wjcc.v7.i23.3990
Figure 2
Figure 2 One third of colorectal cancer specimens (14/45 cases) show triple positivity for ARSA/ARSB/maspin and low circulating ARSB gene expression level (A), as independent negative prognostic factor (B); the overall survival also depends on independently evaluation of protein tissue level of ARSA (C), ARSB (D) and maspin (E).